CRNX NASDAQ
Crinetics Pharmaceuticals, Inc.
1W: +0.2%
1M: +1.7%
3M: +146.1%
YTD: +81.8%
1Y: +177.2%
3Y: +394.2%
5Y: +289.3%
$84.95
Last traded 2026-08-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$42M
Revenue
+2928.4% YoY
$-502M
Net Income
-35.6% YoY
$-425M
Free Cash Flow
-39.1% YoY
99.4%
Gross Margin
-527.3%
Op. Margin
-481.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-42.4%
ROA-38.4%
ROIC-1299.5%
Valuation
P/E-16.8
P/B7.5
EV/EBITDA-5.4
Leverage
Debt/Equity0.04
Current Ratio15.57
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z16.25
Beneish M18.49